Nav: Home

Mechanistic finding may help develop treatment for Ice Bucket Challenge disease

August 01, 2016

A new study by a team of scientists from the University of Malta and the Institut de Génétique Moléculaire de Montpellier (CNRS/Université de Montpellier) could help develop treatment strategies for a crippling disorder that was the focus of the Ice Bucket Challenge, the world's largest global social media phenomenon. The findings uncover a mechanism that explains how motor neuron disease develops.

Motor neuron diseases affect the motor neurons or cells in the brain and spinal cord that control the muscles. They rob patients of their ability to walk, eat, talk or breathe. Amyotrophic lateral sclerosis (ALS) affects adults while spinal muscular atrophy (SMA) mostly strikes young children. SMA patients inherit a flaw in the Survival Motor Neuron (SMN) gene that decimates the levels of the SMN protein, causing motor neurons and associated muscles to die.

The SMN protein has been implicated in the assembly of the splicing machinery that cuts and pastes the cell's genetic instructions together. Whether this basic biological function is disrupted in SMA was unclear. Now, the research team discovered that the disruption of the cellular proteins pICln and Tgs1, two chief players that help assemble the splicing machinery, causes the fruit flies' neuromuscular system to collapse in a similar manner to patients with SMA.

The breakthrough discovery was reported in the journal Neurobiology of Disease and implies that a failure to correctly process the genetic blueprint that produces correctly working proteins is likely to blame for the neuromuscular deficits in young patients with motor neuron disease.

"Therapies have been difficult to develop because of the lack of clarity on how a shortage of the SMN protein leads to motor neuron death and muscle weakness in patients," said the study's lead author Ruben J. Cauchi, PhD, a faculty member of the University of Malta's School of Medicine and Surgery.

The splicing machinery is essential for the health of all cells. However, in humans and flies, when there is a shortfall in the SMN protein, only motor neurons and muscle cells become sick, while the rest mostly survive. "Our study solves this mystery by showing that the motor neurons and muscles are highly sensitive to disturbances in the assembly of the splicing machine, consequently leading to them being selectively injured," remarked Cauchi.

Because of similar symptoms, the hunch that ALS and SMA are related was proven correct with many studies showing the same cellular mechanisms underpin both disorders. The splicing machinery in severely hit in most ALS patients.

"A shared mechanism translates into a common treatment," remarked Rémy Bordonne, PhD, CNRS principal investigator and study co-author. Right now the research team is teasing out further details of the disease mechanism since this will steer researchers on a path towards much-needed treatment for motor neuron diseases.
-end-
The research was funded by the University of Malta Faculty of Medicine & Surgery Dean's Initiative, the Malta Council for Science & Technology, the Embassy of France to Malta, and a Malta Strategic Educational Pathways Scholarship (part-financed by the European Social Fund).

Publication:

Borg, R.M., Fenech Salerno, B., Vassallo, N., Bordonne, R., & Cauchi, R.J. Disruption of snRNP biogenesis factors Tgs1 and pICln induces phenotypes that mirror aspects of SMN-Gemins complex perturbation in Drosophila, providing new insights into spinal muscular atrophy, Neurobiol. Dis. (2016), http://dx.doi.org/10.1016/j.nbd.2016.06.015

University of Malta

Related Spinal Muscular Atrophy Articles:

Spinal muscular atrophy: New clues to cause and treatment
Spinal muscular atrophy is partly due to defects in the sensory neuron synapses that activate motor neurons.
Study opens new line of attack on spinal muscular atrophy
Scientists have discovered a physiological chain of events in animal models in which motor neurons and their communication with muscle become disrupted by the mutation that causes spinal muscular atrophy.
Study compares brain atrophy between typical elderly and 'superagers'
Cognitively average elderly adults demonstrated greater annual whole-brain cortical volume loss over 18 months compared with SuperAgers, adults 80 years and older with memory ability at least as good as that of average middle-age adults, according to a study published by JAMA.
Experiments in mice may help boost newly FDA-approved therapy for spinal muscular atrophy
Johns Hopkins researchers along with academic and drug industry investigators say they have identified a new biological target for treating spinal muscular atrophy.
Study finds new treatment for spinal muscular atrophy safe for infants
Infants as young as five weeks old with the most severe form of spinal muscular atrophy -- a leading genetic cause of infant mortality -- can be treated safely with nusinersen.
The Lancet: Experimental drug for spinal muscular atrophy shows promising early results, prompting phase 3 clinical trial
A new drug for spinal muscular atrophy has shown promising early results in a phase 2 trial involving 20 babies with infantile-onset spinal muscular atrophy.
Different brain atrophy patterns may explain variability in Alzheimers disease symptoms
Mathematical modeling of the brain scans of patients with Alzheimer's disease and others at risk for the devastating neurodegenerative disorder has identified specific patterns of brain atrophy that appear to be related to the loss of particular cognitive abilities.
Ospemifene in vulvovaginal atrophy: Added benefit not proven
The study data allow no conclusion on added benefit: the study populations are unsuitable, two of the three studies are too short, and requirements for the comparator therapy were not met.
Promising new drug could help treat spinal muscular atrophy
Approximately one out of every 40 individuals in the United States is a carrier of the gene responsible for spinal muscular atrophy, a neurodegenerative disease that causes muscles to weaken.
Study explains how a protein deficiency causes spinal muscular atrophy
Research that reveals what goes wrong in SMA and suggests that a mild version of the same genetic defect may protect relatives against infection, which could explain why SMA is a relatively common disease.

Related Spinal Muscular Atrophy Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#529 Do You Really Want to Find Out Who's Your Daddy?
At least some of you by now have probably spit into a tube and mailed it off to find out who your closest relatives are, where you might be from, and what terrible diseases might await you. But what exactly did you find out? And what did you give away? In this live panel at Awesome Con we bring in science writer Tina Saey to talk about all her DNA testing, and bioethicist Debra Mathews, to determine whether Tina should have done it at all. Related links: What FamilyTreeDNA sharing genetic data with police means for you Crime solvers embraced...